Production (Stage)
Verve Therapeutics, Inc.
VERV
$4.36
-$0.02-0.46%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 497.08M | 524.28M | 539.92M | 575.95M | 606.37M |
| Total Receivables | 1.40M | 3.26M | 2.63M | 3.04M | 5.77M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 13.17M | 15.22M | 13.91M | 11.90M | 8.19M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 511.65M | 542.75M | 556.46M | 590.89M | 620.33M |
|
|
|||||
| Total Current Assets | 511.65M | 542.75M | 556.46M | 590.89M | 620.33M |
| Net Property, Plant & Equipment | 94.67M | 96.73M | 99.55M | 101.93M | 104.55M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 7.84M | 7.92M | 7.90M | 8.09M | 7.48M |
| Total Assets | 614.16M | 647.39M | 663.91M | 700.91M | 732.36M |
|
|
|||||
| Total Accounts Payable | 5.35M | 4.52M | 4.64M | 6.83M | 3.05M |
| Total Accrued Expenses | 17.05M | 24.34M | 21.80M | 19.45M | 16.55M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 10.52M | 10.44M | 10.37M | 10.29M | 10.22M |
| Total Finance Division Other Current Liabilities | 19.06M | 3.61M | 5.84M | 3.79M | 1.47M |
| Total Other Current Liabilities | 19.06M | 3.61M | 5.84M | 3.79M | 1.47M |
| Total Current Liabilities | 51.98M | 42.91M | 42.64M | 40.37M | 31.29M |
|
|
|||||
| Total Current Liabilities | 51.98M | 42.91M | 42.64M | 40.37M | 31.29M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 58.12M | 59.54M | 60.89M | 62.18M | 63.45M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 30.55M | 51.54M | 51.83M | 52.27M | 54.54M |
| Total Liabilities | 140.65M | 153.99M | 155.36M | 154.82M | 149.29M |
|
|
|||||
| Common Stock & APIC | 1.25B | 1.24B | 1.20B | 1.19B | 1.18B |
| Retained Earnings | -774.05M | -743.01M | -692.98M | -642.85M | -593.04M |
| Treasury Stock & Other | 393.00K | 428.00K | 1.14M | -615.00K | -500.00K |
| Total Common Equity | 473.51M | 493.40M | 508.55M | 546.09M | 583.07M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 473.51M | 493.40M | 508.55M | 546.09M | 583.07M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 473.51M | 493.40M | 508.55M | 546.09M | 583.07M |
|
|
|||||